Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Current practical applications of diagnostic immunohistochemistry in breast pathology.

Lerwill MF.

Am J Surg Pathol. 2004 Aug;28(8):1076-91. Review.

PMID:
15252316
2.

[Diagnostic immunohistochemistry of breast epithelial lesions].

Balaton AJ, Guinebretière JM, Penault-Llorca F.

Ann Pathol. 2003 Dec;23(6):570-81. Review. French.

PMID:
15094595
3.

Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions.

MacGrogan G, Arnould L, de Mascarel I, Vincent-Salomon A, Penault-Llorca F, Lacroix-Triki M, Bibeau F, Baranzelli MC, Fridman V, Antoine M, Bécette V, Brouste V, Jacquemier J, Mathoulin-Pélissier S; GEFPICS group.

Histopathology. 2008 May;52(6):689-97. doi: 10.1111/j.1365-2559.2008.03016.x. Epub 2008 Apr 5.

PMID:
18397281
4.
5.

The role of immunohistochemistry in the differential diagnosis of breast lesions.

Moriya T, Kozuka Y, Kanomata N, Tse GM, Tan PH.

Pathology. 2009 Jan;41(1):68-76. doi: 10.1080/00313020802563544.

PMID:
19089742
6.

Use of immunohistochemistry in diagnosis of breast epithelial lesions.

Bhargava R, Dabbs DJ.

Adv Anat Pathol. 2007 Mar;14(2):93-107. Review.

PMID:
17471116
7.

New trends of immunohistochemistry for making differential diagnosis of breast lesions.

Moriya T, Kasajima A, Ishida K, Kariya Y, Akahira J, Endoh M, Watanabe M, Sasano H.

Med Mol Morphol. 2006 Mar;39(1):8-13. Review.

PMID:
16575508
8.

Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.

Jeschke U, Mylonas I, Kuhn C, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.

Anticancer Res. 2007 Jul-Aug;27(4A):1969-74.

9.

Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions.

Moriya T, Kanomata N, Kozuka Y, Fukumoto M, Iwachido N, Hata S, Takahashi Y, Miura H, Ishida K, Watanabe M.

Breast Cancer. 2009;16(3):173-8. doi: 10.1007/s12282-009-0127-7. Epub 2009 May 28.

PMID:
19475479
10.

Diagnostic role of immunohistochemistry in the evaluation of breast pathology specimens.

Zhao L, Yang X, Khan A, Kandil D.

Arch Pathol Lab Med. 2014 Jan;138(1):16-24. doi: 10.5858/arpa.2012-0440-RA. Review.

PMID:
24377808
11.

Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases.

Carter MR, Hornick JL, Lester S, Fletcher CD.

Am J Surg Pathol. 2006 Mar;30(3):300-9.

PMID:
16538049
13.

P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ.

Paredes J, Lopes N, Milanezi F, Schmitt FC.

Virchows Arch. 2007 Jan;450(1):73-80. Epub 2006 Nov 23.

PMID:
17123107
14.

Differentiation of tumours of ductal and lobular origin: I. Proteomics of invasive ductal and lobular breast carcinomas.

Turashvili G, Bouchal J, Burkadze G, Kolár Z.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Jun;149(1):57-62. Review.

15.

E-cadherin expression correlates with histologic type but not tumour grade in invasive breast cancer.

Nurismah MI, Noriah O, Suryati MY, Sharifah NA.

Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):699-702.

16.

Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions.

Tan PH, Lui GG, Chiang G, Yap WM, Poh WT, Bay BH.

Histopathology. 2004 Oct;45(4):343-51.

PMID:
15469472
17.

D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.

Rabban JT, Chen YY.

Hum Pathol. 2008 Feb;39(2):175-83. doi: 10.1016/j.humpath.2007.06.018.

PMID:
18206495
18.

Tubulolobular carcinoma of the breast: an analysis of 27 cases of a tumor with a hybrid morphology and immunoprofile.

Wheeler DT, Tai LH, Bratthauer GL, Waldner DL, Tavassoli FA.

Am J Surg Pathol. 2004 Dec;28(12):1587-93.

PMID:
15577677
19.

Clarification of criteria for (i +) nodes associated with breast carcinoma.

Tickman RJ, Wang NP.

Am J Surg Pathol. 2005 Jan;29(1):136; author reply 136. No abstract available.

PMID:
15613871
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk